Keyphrases
2,4-dioxobutanoic Acids
7%
Addiction
17%
Adverse Drug Reaction
7%
Alcohol
19%
Amphetamine
10%
Antidepressants
9%
Antipsychotics
7%
Appearance Anxiety
6%
Benzodiazepines
21%
Biological Activity
7%
Cannabinoids
7%
Cannabis
18%
Cathinones
10%
Cocaine
20%
Cognitive Enhancer
8%
Computational Approach
6%
Coroner
7%
COVID-19
12%
COVID-19 Pandemic
15%
Dendrimer
11%
Designer Benzodiazepines
7%
Diketopyrrolopyrrole
11%
Drug Abuse
19%
Drug Addiction
9%
Drug Dependence
13%
Drug Misuse
14%
Drug Use
13%
Drug-related Deaths
15%
Ecstasy
20%
Europe
9%
European Medicines Agency
11%
Fatality
35%
Harm Reduction
9%
Health Professionals
11%
Health Risk
9%
Heroin
10%
Illicit Drugs
10%
Image-enhancing Drugs
11%
Italy
16%
Ketamine
22%
Khat
8%
Kratom
16%
Legal Highs
23%
Major Depressive Disorder
8%
Medical Inpatients
7%
Mental Health
7%
Mephedrone
21%
Meta-analysis
7%
Methoxetamine
10%
Mitragyna Speciosa
7%
Molecular Modeling
7%
Motivation
7%
National Program
6%
New Drugs
11%
New Psychoactive Substances
40%
Novel Psychoactive Substances
100%
Older Adults
10%
Opiates
12%
Opioids
14%
Over-the-counter Drugs
7%
Performance-enhancing Drugs
11%
Pharmacovigilance Database
11%
Phenyl
12%
Popular
8%
Prescription Drugs
13%
Problematic Internet Use
10%
Psychedelics
12%
Psychiatry
6%
Psychoactive Substance Use
9%
Psychological Distress
7%
Psychonauts
15%
Psychopathological
21%
Psychosis
10%
Public Health
6%
Public Health Risk
10%
PubMed
8%
Recreational Drugs
15%
Recreational Use
10%
Seizure
7%
Self-medication
7%
Selling
15%
Social Media
11%
Spices
8%
Staphylococcus Aureus
7%
Stimulants
21%
Substance Abuse
12%
Substance Misuse
13%
Substance Use
14%
Substance Use Disorder
11%
Suicide
9%
Symptom Checklist-90 (SCL-90)
8%
Synthetic Cannabinoids
21%
Synthetic Cathinones
7%
Systematic Literature Review
8%
United Kingdom
24%
Venlafaxine
8%
Wales
8%
World Wide Web
30%
Young People
9%
μ-opioid Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
11%
Adverse Event
17%
Amino Acid
5%
Amphetamine Derivative
5%
Antibacterial Activity
5%
Antidepressant
13%
Antiinfective Agent
11%
Base
5%
Benzodiazepine
5%
Biological Activity
5%
Cannabinoid
28%
Cannabinoid Receptor Agonist
5%
Cannabis
21%
Catha Edulis Extract
7%
Cathinone
19%
Controlled Substance
6%
Dendrimer
14%
Designer Drug
8%
Dextromethorphan
6%
Diamorphine
12%
Disease
24%
Drug Dependence
28%
Drug Market
7%
Drug Misuse
11%
Duragesic
6%
Effusion
6%
Ethanol
16%
Fatality
40%
FDA Adverse Event Reporting System
5%
Gabapentin
6%
Gabapentinoid
6%
Gamma-Butyrolactone
5%
Hallucination
6%
Health Hazard
13%
Illicit Drug
13%
Inductively Coupled Plasma
5%
Infection
10%
Ketamine
20%
Malignant Neoplasm
5%
MDMA
9%
Mephedrone
23%
Methoxetamine
8%
Mitragyna speciosa
14%
Non Prescription Drug
7%
Observational Study
5%
Opiate
47%
PEGylation
5%
Pharmacovigilance
16%
Phenethylamine Derivative
5%
Posttraumatic Stress Disorder
7%
Pregabalin
7%
Prescription Drug
10%
Prevalence
18%
Prodrug
5%
Psychosis
6%
Psychotomimetic
25%
Psychotropic Agent
25%
Quetiapine
6%
Receptor
7%
Recreational Drug
19%
Self-Medication
7%
Semaglutide
5%
Side Effect
19%
Staphylococcus Aureus
6%
Tablet
9%
Toxic Injury
28%
Toxicology
7%
Typical Antipsychotic
6%
Venlafaxine
8%